Vitamin A Treatment for Measles in Children
For children with measles, administer vitamin A 200,000 IU orally for children ≥12 months, 100,000 IU for infants 6-11 months, and 50,000 IU for infants <6 months, given as two doses 24 hours apart, regardless of nutritional status.
Vitamin A Dosing Protocol
The vitamin A regimen is critical for reducing measles-related morbidity and mortality, particularly in hospitalized children and those with complications:
Age-Based Dosing (Two-Dose Regimen):
- Children ≥12 months: 200,000 IU PO on days 1 and 2
- Infants 6-11 months: 100,000 IU PO on days 1 and 2
- Infants <6 months: 50,000 IU PO on days 1 and 2
Route and Administration:
- Oral administration 1
- Shake well before use 1
- Both doses should be given even if the child appears to be recovering
Indications for Vitamin A in Measles:
- All children hospitalized with measles
- Children with measles complications (pneumonia, croup, diarrhea)
- Children with immunodeficiency
- Children with evidence of vitamin A deficiency (night blindness, Bitot spots, xerophthalmia)
- Consider for all children with measles in areas with vitamin A deficiency or measles mortality >1%
Supportive Medications
Antipyretics:
- Acetaminophen: 10-15 mg/kg PO/PR every 4-6 hours (max 5 doses/24 hours)
- Ibuprofen: 5-10 mg/kg PO every 6-8 hours for children ≥6 months
- Avoid aspirin due to Reye syndrome risk
Antibiotics:
Antibiotics are not routinely indicated for uncomplicated measles but should be administered for:
- Bacterial pneumonia: Amoxicillin 80-90 mg/kg/day divided BID or ceftriaxone 50-100 mg/kg/day IV/IM
- Otitis media: Amoxicillin 80-90 mg/kg/day divided BID for 5-10 days
- Secondary bacterial infections: Culture-directed therapy when possible
Additional Supportive Care:
- Maintain hydration (oral or IV fluids as needed)
- Nutritional support
- Humidified oxygen for respiratory distress
- Isolation precautions (airborne + contact for 4 days after rash onset)
Critical Caveats
Vitamin A toxicity warning: Keep out of reach of children; overdosage requires immediate poison control contact 1. However, the two-dose regimen described above is safe and evidence-based.
Do not delay vitamin A administration while awaiting laboratory confirmation of measles—clinical diagnosis is sufficient to initiate treatment.
Vaccination considerations: The guidelines provided focus on MMR vaccination schedules 2, 3, but these are preventive measures. For acute measles treatment, vitamin A remains the cornerstone intervention for reducing complications and mortality.
Post-exposure prophylaxis: Unvaccinated exposed contacts should receive MMR within 72 hours of exposure 2, but this is distinct from treating active measles disease.